• Astepro® (azelastine hydrochloride) Nasal Spray 0.15%

    Important Risk Information:
    •Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%.
    •Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%.
    •In clinical studies, the most common reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%,6%), nasal discomfort (4%,3%), epistaxis (2%,1%) and sneezing (1%,2%).
    •Please see full Prescribing Information.



  • BiferaRxTM Iron Supplement Tablets


    WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.



  • Cesamet® (nabilone) Capsules




  • Muse® (alprostadil) Urethral Suppository



  • PreferaOB® Family of Products


    WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Featured Products
Astepro 0.15Bifera Rx
CesametEdluar
MuseOnsolis
Prefera OB 

Coming Soon
Dymista® Nasal Spray 

Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB.

The Meda Pharmaceutical product portfolio is focused primarily on respiratory, allergy, central nervous system, gastroenterology, musculoskeletal, rheumatology, erectile dysfunction, and women's health products.